Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study

被引:28
|
作者
Lim, Ching Jou [1 ,4 ]
Cheng, Allen C. [2 ,4 ]
Kong, David C. M. [1 ,4 ]
Peleg, Anton Y. [3 ,4 ]
机构
[1] Monash Univ, Ctr Med Use & Safety, Melbourne, Vic 3800, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3800, Australia
[3] Monash Univ, Dept Microbiol, Sch Biol Sci, Melbourne, Vic 3800, Australia
[4] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
Multidrug-resistant; Empiric antibiotic therapy; Bacteraemia; Enterobacteriaceae; Staphylococcus; STAPHYLOCOCCUS-AUREUS BACTEREMIA; GRAM-NEGATIVE BACTERIA; RISK-FACTORS; ANTIMICROBIAL THERAPY; MORTALITY; IMPACT; PATHOGENS; INFLUX; DEFINITION; PNEUMONIA;
D O I
10.1186/1471-2334-14-126
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Multidrug-resistant (MDR) organisms have been increasingly reported at hospital admission. Recognising the magnitude, trend and predictors for MDR organisms in community-onset bloodstream infections (COBSI) is crucial for guiding empiric antibiotic prescribing. Methods: Positive blood culture isolates recovered from patients presenting to the emergency department during a ten-year period (1st Jan 2002-31st Dec 2011) were assessed. Trend analyses of MDR organisms were performed. Risk factors for COBSI caused by an MDR organism and predictors for 30-day mortality were also determined. Results: A total of 1721 positive blood culture isolates were identified during the study period with a yearly incidence of 30-43 isolates/10 000 ED presentations. The proportion of MDR Escherichia coli causing COBSI increased from 9%-26% (P < 0.001), whilst methicillin-resistant Staphylococcus aureus remained at high levels (20%-30%). A total of 360 patients were included in a matched case-control (1: 1) study, and residents in long-term care facilities (adjusted odds ratio [AOR], 4.9 [95% CI, 2.1-11.6]), home wound care (AOR, 5.5 [95% CI, 1.6-18.7]), underlying immunosuppression (AOR, 3.5 [95% CI, 1.6-7.7]), recent surgery (AOR, 3.5 [95% CI, 1.1-11.6]), and exposure to antibiotics within 3 months (AOR, 5.5 [95% CI, 2.8-10.6]) were independently associated with MDR COBSI. High risk source of COBSI, age and Pitt bacteraemia score were independent predictors for 30-day mortality. Conclusions: A concerning trend in MDR organisms causing bloodstream infection from the community is occurring. Risk factors for MDR organisms have been identified to assist in empiric antibiotic prescribing for those presenting to hospital with sepsis.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Efficacy of Infection Control Measures in Managing Outbreaks of Multidrug-Resistant Organisms in Burn Units
    Wang, Chunyang
    Zhang, Feng
    Breland, Andrew
    Lineaweaver, William C.
    ANNALS OF PLASTIC SURGERY, 2021, 86 (4S) : S454 - S457
  • [32] Risk factors for infection with multidrug-resistant organisms in Haryana, India
    Kalluru, Shilpa
    Eggers, Shoshannah
    Barker, Anna
    Shirley, Daniel
    Sethi, Ajay K.
    Sengupta, Sharmila
    Yeptho, Kajal
    Safdar, Nasia
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (03) : 341 - 345
  • [33] Infection Management and Multidrug-Resistant Organisms in Nursing Home Residents With Advanced Dementia
    Mitchell, Susan L.
    Shaffer, Michele L.
    Loeb, Mark B.
    Givens, Jane L.
    Habtemariam, Daniel
    Kiely, Dan K.
    D'Agata, Erika
    JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1660 - 1667
  • [34] Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study
    Ahmad, Ahsan M.
    Akhtar, Saeed
    Hasan, Rumina
    Khan, Javaid A.
    Hussain, Syed F.
    Rizvi, Nadeem
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2012, 1 (03) : 137 - 142
  • [35] Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms
    Wang, Joyce
    Foxman, Betsy
    Mody, Lona
    Snitkin, Evan S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (39) : 10467 - 10472
  • [36] A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
    Gomez-Zorrilla, Silvia
    Becerra-Aparicio, Federico
    Lopez Montesinos, Inmaculada
    Ruiz de Gopegui, Enrique
    Grau, Inmaculada
    Pintado, Vicente
    Padilla, Belen
    Benito, Natividad
    Boix-Palop, Lucia
    Carmen Farinas, Maria
    Penaranda, Maria
    Rocio Gamallo, Maria
    Antonio Martinez, Jose
    Morte-Romea, Elena
    Luis Del Pozo, Jose
    Duran-Jorda, Xavier
    Diaz-Reganon, Jazmin
    Lopez-Mendoza, Diego
    Canton, Rafael
    Oliver, Antonio
    Ruiz-Garbajosa, Patricia
    Pablo Horcajada, Juan
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2677 - 2699
  • [37] Multidrug-Resistant Acinetobacter baumannii May Cause Patients to Develop Polymicrobial Bloodstream Infection
    Chen, Qingqing
    Zheng, Zhencang
    Shi, Qingxin
    Wu, Huijuan
    Li, Yuping
    Zheng, Cheng
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [38] Clinical features and microbiological characteristics of hospital- and community-onset Escherichia coli bloodstream infection
    Chen, Xiao
    Zou, Qianda
    Zhang, Weili
    Wang, Ruonan
    Yu, Fei
    Chen, Yu
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (02) : 178 - 187
  • [39] Multidrug-Resistant Bloodstream Infections in Internal Medicine: Results from a Single-Center Study
    Pace, Edoardo
    Bracco, Christian
    Magnino, Corrado
    Martini, Marco Badinella
    Serraino, Cristina
    Brignone, Chiara
    Testa, Elisa
    Fenoglio, Luigi Maria
    Porta, Massimo
    SOUTHERN MEDICAL JOURNAL, 2022, 115 (05) : 333 - 339
  • [40] Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study
    Stosic, Maja
    Vukovic, Dejana
    Babic, Dragan
    Antonijevic, Gordana
    Foley, Kristie L.
    Vujcic, Isidora
    Grujicic, Sandra Sipetic
    BMC PUBLIC HEALTH, 2018, 18